Insights

Reset

ADVI insights

Insights,

ADVI Analysis: HRSA 340B Covered Entity Audits
ADVI Angle Vertical

Insights,

| Allison Schneider, MHA - Director

Prescription Drug Affordability Boards: Access Concerns and Implications for Rare Diseases and Conditions

Insights,

| Charles Sewell - Senior Associate

ADVI Analysis: MACPAC October 2024 Meeting

Insights,

| Brenna Raines, MHA - Vice President

ADVI Instant: CMS Releases 2026 Notice of Benefit and Payment Parameters Proposed Rule
View All

Case Studies

Case Study: Rare Disease State Policy Engagement

Case Study: Medicare Part D Liability Model 

Case Study: Understanding the Impact of the MFPs for IPAY 2026

Case Study: Strengthening Positioning for IRA Drug Price Negotiation
View All

Events

ADVI Health at Access Forum Events ADVI Health is Attending Access Forum US
Events ADVI Health is Attending ISPOR Annual 2025
Events ADVI Health is Attending Asembia’s AXS25 Summit
Events ADVI Health is Attending AMCP 2025
Events ADVI Health’s Alicia Silver at Tandem Meetings in Honolulu, HI
Events ADVI Health Presentation at the AMCP Foundation Symposium
View All

News

In The News ADVI Health appoints Sandy Royden to its Board of Directors
In The News John Coster Discusses GLP-1 Coverage Among Medicare and Medicaid with Pink Sheet
In The News Matt Salo Named Washingtonian’s 500 Most Influential for Second Year in a Row
In The News ADVI Health’s Expertise on CAR-T Disparities Featured in STAT
In The News John Coster Discusses Drug Pricing Executive Order in STAT
In The News Lindsay Bealor Greenleaf Joins Managed Healthcare Executive’s Webinar Discussing Healthcare in the Early Days of the Second Trump Administration
View All

Videos

ADVI Experts Lindsay Greenleaf and Mary Roberts Share Insight Ahead of #AXS25

Marci Mutti Shares Insight on What to Look Out for in 2025

Mary Roberts Shares 2025 Market Access Insights

Michael Beebe Shares Insight on Predicted 2025 Developments and Challenges
View All